 CHESTERBROOK, Penn., Aug. 30, 2021 GLOBE NEWSWIRE -- Trevena, Inc. Nasdaq: TRVN, a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system CNS disorders, today announced the acceptance of two abstracts at ANESTHESIOLOGY 2021. Both abstracts highlight safety data from the OLINVYK oliceridine injection program. The meeting is sponsored by the American Society of Anesthesiologists and will be held on October 8th to 12th in San Diego, California. 